All 3,378 procedure codes billed by Medicaid providers in Wisconsin, ranked by total spending.
| # | Code | Description | Total Paid |
|---|---|---|---|
| 1 | H2017 | Psychosocial rehabilitation services, per 15 minutes | $1.09B |
| 2 | T1016 | Case management, each 15 minutes | $387.78M |
| 3 | 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | $334.71M |
| 4 | 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | $303.76M |
| 5 | T1015 | Clinic visit/encounter, all-inclusive | $294.24M |
| 6 | 81528 | Oncology (colorectal) screening, quantitative real-time target and signal amplification | $276.87M |
| 7 | 99283 | Emergency department visit for the evaluation and management, moderate severity | $222.35M |
| 8 | T2046 | Hospice long term care, room and board only; per diem | $209.88M |
| 9 | 99284 | Emergency department visit for the evaluation and management, high severity | $209.16M |
| 10 | T1017 | Targeted case management, each 15 minutes | $176.31M |
| 11 | 99199 | Unlisted special service, procedure or report | $166.13M |
| 12 | 97153 | Adaptive behavior treatment by protocol, administered by technician, each 15 minutes | $165.32M |
| 13 | S9484 | Crisis intervention mental health services, per hour | $159.48M |
| 14 | 96361 | Intravenous infusion, hydration; each additional hour | $150.24M |
| 15 | 90999 | Unlisted dialysis procedure, inpatient or outpatient | $147.16M |
| 16 | H0039 | Assertive community treatment, face-to-face, per 15 minutes | $137.60M |
| 17 | 90837 | Psychotherapy, 53 minutes with patient | $117.59M |
| 18 | T1019 | Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant) | $115.46M |
| 19 | T2016 | Habilitation, residential, waiver; per diem | $114.59M |
| 20 | H2012 | Behavioral health day treatment, per hour | $114.54M |
| 21 | 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | $111.68M |
| 22 | S5125 | Attendant care services; per 15 minutes | $96.31M |
| 23 | H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | $95.46M |
| 24 | H0018 | Behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem | $94.97M |
| 25 | 90834 | Psychotherapy, 45 minutes with patient | $86.51M |
| 26 | 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | $85.48M |
| 27 | 99282 | Emergency department visit for the evaluation and management, low to moderate severity | $74.66M |
| 28 | 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | $74.59M |
| 29 | A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | $73.53M |
| 30 | T1005 | Respite care services, up to 15 minutes | $72.01M |
| 31 | 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | $67.81M |
| 32 | H0003 | Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs | $67.75M |
| 33 | 97155 | Adaptive behavior treatment with protocol modification, administered by physician, each 15 minutes | $62.25M |
| 34 | 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | $62.12M |
| 35 | A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | $61.82M |
| 36 | 80053 | Comprehensive metabolic panel | $60.61M |
| 37 | S5150 | Unskilled respite care, not hospice; per 15 minutes | $57.68M |
| 38 | 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | $55.91M |
| 39 | 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | $48.38M |
| 40 | D8670 | Periodic orthodontic treatment visit | $47.67M |
| 41 | 74177 | Computed tomography, abdomen and pelvis; with contrast material | $47.00M |
| 42 | 70450 | Computed tomography, head or brain; without contrast material | $46.98M |
| 43 | U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | $46.87M |
| 44 | 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | $43.06M |
| 45 | T2003 | Non-emergency transportation; encounter/trip | $39.97M |
| 46 | H1010 | Non-medical family planning education, per session | $37.27M |
| 47 | S4993 | Contraceptive pills for birth control | $35.89M |
| 48 | 97530 | Therapeutic activities, direct patient contact, each 15 minutes | $35.33M |
| 49 | 99215 | Prolong outpt/office vis | $33.47M |
| 50 | D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | $32.84M |
| 51 | D1120 | Prophylaxis - child | $32.28M |
| 52 | D2930 | Prefabricated stainless steel crown - primary tooth | $32.07M |
| 53 | S9485 | Crisis intervention mental health services, per diem | $30.63M |
| 54 | D1351 | Sealant - per tooth | $30.41M |
| 55 | 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | $29.92M |
| 56 | D0120 | Periodic oral evaluation - established patient | $27.96M |
| 57 | D1206 | Topical application of fluoride varnish | $27.55M |
| 58 | 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | $27.29M |
| 59 | 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | $27.00M |
| 60 | 99600 | Unlisted home visit service or procedure | $26.65M |
| 61 | T2023 | Targeted case management; per month | $26.58M |
| 62 | 80048 | Basic metabolic panel (calcium, ionized) | $26.33M |
| 63 | H0022 | Alcohol and/or drug intervention service (planned facilitation) | $26.09M |
| 64 | 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | $25.84M |
| 65 | D1110 | Prophylaxis - adult | $25.56M |
| 66 | S9125 | Respite care, in the home, per diem | $24.92M |
| 67 | 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | $24.69M |
| 68 | D7140 | Extraction, erupted tooth or exposed root | $24.51M |
| 69 | E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | $22.39M |
| 70 | 88305 | Level IV - Surgical pathology, gross and microscopic examination | $22.30M |
| 71 | D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | $22.27M |
| 72 | 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | $21.67M |
| 73 | 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | $20.69M |
| 74 | 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | $20.30M |
| 75 | 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | $20.08M |
| 76 | 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | $20.02M |
| 77 | S5130 | Homemaker service, nos; per 15 minutes | $19.76M |
| 78 | 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | $19.52M |
| 79 | G0176 | Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more) | $19.15M |
| 80 | 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | $18.82M |
| 81 | H2016 | Comprehensive community support services, per diem | $18.63M |
| 82 | 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | $18.00M |
| 83 | D0150 | Comprehensive oral evaluation - new or established patient | $17.61M |
| 84 | T2017 | Habilitation, residential, waiver; 15 minutes | $17.56M |
| 85 | D2391 | Resin-based composite - one surface, posterior, primary or permanent | $16.86M |
| 86 | 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | $16.80M |
| 87 | 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | $16.80M |
| 88 | T2021 | Day habilitation, waiver; per 15 minutes | $16.78M |
| 89 | S5151 | Unskilled respite care, not hospice; per diem | $16.75M |
| 90 | 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | $16.57M |
| 91 | G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | $16.34M |
| 92 | D0210 | Intraoral - complete series of radiographic images | $16.15M |
| 93 | 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | $15.47M |
| 94 | D8080 | Comprehensive orthodontic treatment of the adolescent dentition | $15.44M |
| 95 | 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | $15.28M |
| 96 | 84443 | Thyroid stimulating hormone (TSH) | $15.26M |
| 97 | S5140 | Foster care, adult; per diem | $14.93M |
| 98 | 0365T | $14.65M | |
| 99 | 99232 | Subsequent hospital care, per day, moderate complexity | $14.06M |
| 100 | A0390 | Als mileage (per mile) | $13.96M |
| 101 | H2036 | Alcohol and/or other drug treatment program, per diem | $13.95M |
| 102 | T2040 | Financial management, self-directed, waiver; per 15 minutes | $13.90M |
| 103 | 41899 | Unlisted procedure, dentoalveolar structures | $13.75M |
| 104 | J0585 | Injection, onabotulinumtoxina, 1 unit | $13.72M |
| 105 | G0463 | Hospital outpatient clinic visit for assessment and management of a patient | $13.69M |
| 106 | G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | $13.56M |
| 107 | E0601 | Continuous positive airway pressure (cpap) device | $13.27M |
| 108 | 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | $13.10M |
| 109 | 80061 | Lipid panel | $13.01M |
| 110 | A7030 | Full face mask used with positive airway pressure device, each | $12.91M |
| 111 | 99281 | Emergency department visit for the evaluation and management, self-limited or minor | $12.74M |
| 112 | 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | $12.62M |
| 113 | 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | $12.31M |
| 114 | 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | $12.06M |
| 115 | A0380 | Bls mileage (per mile) | $12.05M |
| 116 | D0140 | Limited oral evaluation - problem focused | $11.95M |
| 117 | T2042 | Hospice routine home care; per diem | $11.89M |
| 118 | 99233 | Prolong inpt eval add15 m | $11.86M |
| 119 | D0330 | Panoramic radiographic image | $11.70M |
| 120 | D0274 | Bitewings - four radiographic images | $11.51M |
| 121 | G0378 | Hospital observation service, per hour | $11.33M |
| 122 | 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | $11.19M |
| 123 | B4035 | Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape | $10.86M |
| 124 | 99509 | Home visit for assistance with activities of daily living and personal care | $10.77M |
| 125 | 90792 | Psychiatric diagnostic evaluation with medical services | $10.48M |
| 126 | 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | $10.25M |
| 127 | D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | $10.12M |
| 128 | T1026 | Intensive, extended multidisciplinary services provided in a clinic setting to children with complex medical, physical, mental and psychosocial impairments, per hour | $10.11M |
| 129 | A9999 | Miscellaneous dme supply or accessory, not otherwise specified | $9.93M |
| 130 | 71046 | Radiologic examination, chest; 2 views | $9.74M |
| 131 | 90378 | $9.69M | |
| 132 | U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | $9.66M |
| 133 | 90853 | Group psychotherapy (other than of a multiple-family group) | $9.61M |
| 134 | T2020 | Day habilitation, waiver; per diem | $9.50M |
| 135 | 71275 | Computed tomographic angiography, chest, with contrast material | $9.45M |
| 136 | T2037 | Therapeutic camping, day, waiver; each session | $9.24M |
| 137 | G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | $9.24M |
| 138 | 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | $9.22M |
| 139 | 83036 | Hemoglobin; glycosylated (A1C) | $9.17M |
| 140 | 87086 | Culture, bacterial; quantitative colony count, urine | $9.10M |
| 141 | P9016 | Red blood cells, leukocytes reduced, each unit | $9.06M |
| 142 | 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | $9.01M |
| 143 | 74176 | Computed tomography, abdomen and pelvis; without contrast material | $8.85M |
| 144 | H0043 | Supported housing, per diem | $8.77M |
| 145 | 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | $8.66M |
| 146 | 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | $8.63M |
| 147 | 81025 | $8.53M | |
| 148 | 45380 | Colonoscopy, flexible; with biopsy, single or multiple | $8.51M |
| 149 | 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | $8.51M |
| 150 | D0220 | Intraoral - periapical first radiographic image | $8.47M |
| 151 | J9271 | Injection, pembrolizumab, 1 mg | $8.30M |
| 152 | 81001 | $8.30M | |
| 153 | S5135 | Companion care, adult (e.g., iadl/adl); per 15 minutes | $8.05M |
| 154 | 97799 | $8.05M | |
| 155 | T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | $8.02M |
| 156 | 84484 | $8.01M | |
| 157 | 90791 | Psychiatric diagnostic evaluation | $7.94M |
| 158 | T2028 | Specialized supply, not otherwise specified, waiver | $7.92M |
| 159 | 76819 | Fetal biophysical profile; without non-stress testing | $7.86M |
| 160 | 98940 | $7.81M | |
| 161 | S0215 | Non-emergency transportation; mileage, per mile | $7.78M |
| 162 | 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | $7.72M |
| 163 | 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | $7.66M |
| 164 | Q3014 | Telehealth originating site facility fee | $7.35M |
| 165 | 90832 | Psychotherapy, 30 minutes with patient | $7.31M |
| 166 | B4149 | Enteral formula, manufactured blenderized natural foods with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit | $7.30M |
| 167 | D0272 | Bitewings - two radiographic images | $7.26M |
| 168 | D1208 | Topical application of fluoride, excluding varnish | $7.19M |
| 169 | 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | $7.15M |
| 170 | 0369T | $7.01M | |
| 171 | S5110 | Home care training, family; per 15 minutes | $7.01M |
| 172 | 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | $6.98M |
| 173 | 77067 | Screening mammography, bilateral, including computer-aided detection | $6.98M |
| 174 | 80050 | General health panel | $6.91M |
| 175 | 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | $6.88M |
| 176 | 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | $6.84M |
| 177 | 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | $6.53M |
| 178 | U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | $6.50M |
| 179 | A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | $6.49M |
| 180 | D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | $6.45M |
| 181 | E0562 | Humidifier, heated, used with positive airway pressure device | $6.41M |
| 182 | A9150 | Non-prescription drugs | $6.36M |
| 183 | 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | $6.35M |
| 184 | A0431 | Ambulance service, conventional air services, transport, one way (rotary wing) | $6.32M |
| 185 | T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | $6.23M |
| 186 | 99309 | Subsequent nursing facility care, per day, low to moderate complexity | $6.18M |
| 187 | E0431 | Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing | $6.08M |
| 188 | D0230 | Intraoral - periapical each additional radiographic image | $6.07M |
| 189 | S0281 | Medical home program, comprehensive care coordination and planning, maintenance of plan | $6.05M |
| 190 | 92015 | Determination of refractive state | $6.02M |
| 191 | T1003 | Lpn/lvn services, up to 15 minutes | $6.02M |
| 192 | 83880 | $5.99M | |
| 193 | 71045 | Radiologic examination, chest; single view | $5.98M |
| 194 | H2021 | Community-based wrap-around services, per 15 minutes | $5.94M |
| 195 | 59025 | Fetal non-stress test | $5.88M |
| 196 | 92340 | Fitting of spectacles, except for aphakia; monofocal | $5.84M |
| 197 | 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | $5.83M |
| 198 | 70551 | Magnetic resonance imaging, brain; without contrast material | $5.80M |
| 199 | 90686 | $5.78M | |
| 200 | 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | $5.76M |